comparemela.com

Latest Breaking News On - Sonivie ltd - Page 2 : comparemela.com

Sol Gel Technologies : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 26, 2023 . | June 21, 2023

Columbia universityNew yorkUnited statesNew york stock exchangeTel avivNess zionaUnited kingdomIsrael generalState of israelExalenz bioscienceBen zviShmuel muli ben zviTami fishman jutkowitzSharon kochanJonathanb siegalHani lerman

EQS-News: Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension

EQS-News: Andera Partners / Key word(s): Financing Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension 10.01.2023 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Andera Partners invests in S.

United statesFrance generalTomaso zambelliAndera croissanceEurope amundiRaymondw cohenZvika slovinZeev zehaviMc servicesSonivie ltdDigital technologyGroup of operational holding companiesDistribution servicesBandera coAndera life sciencesTechwald holding

SoniVie Raises $60m in Round C Financing, and Appoints New Board Members

/PRNewswire/ SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today.

United statesFrance generalTomaso zambelliAndera croissanceEurope amundiRaymondw cohenZvika slovinZeev zehaviSonivie ltdDigital technologyGroup of operational holding companiesPrnewswire sonivie ltdBandera coAndera life sciencesTechwald holdingEnergy environment

SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study

/PRNewswire/ SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) System to treat a variety of.

United statesRosh haayinTomaso zambelliMichael jonasChristian spauldingPrnewswire sonivieKaplan medical centerTherapeutic intra vascular ultrasoundRenal artery denervationProfessor michael jonasPrincipal investigatorRenal denervationUltrasonic denervation systemSonivie ltd

Israeli company SoniVie receives FDA approval for hypertension treatment

SoniVie’s treatment is called TIVUS – an innovative Ultrasound system that treats Hypertension patients with Renal Artery Denervation.

United statesWhite oakTomaso zambelliChristian spauldingSonivie ltdDrug administrationInvestigational device exemptionResistant hypertensionRenal arteryRenal denervationUltrasound denervationChief marketing officer

vimarsana © 2020. All Rights Reserved.